|
WHSC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.559600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.015440E-01 |
| Normal-vs-Stage2 |
2.975000E-01 |
| Normal-vs-Stage3 |
7.839000E-01 |
| Normal-vs-Stage4 |
1.669710E-02 |
| Stage1-vs-Stage2 |
8.394600E-01 |
| Stage1-vs-Stage3 |
1.202640E-01 |
| Stage1-vs-Stage4 |
9.054100E-02 |
| Stage2-vs-Stage3 |
4.120800E-01 |
| Stage2-vs-Stage4 |
1.087240E-01 |
| Stage3-vs-Stage4 |
2.329800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.810300E-02 |
| Normal-vs-AfricanAmerican |
1.406440E-01 |
| Normal-vs-Asian |
4.602600E-03 |
| Caucasian-vs-AfricanAmerican |
8.767600E-01 |
| Caucasian-vs-Asian |
1.235970E-01 |
| AfricanAmerican-vs-Asian |
6.002000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.702770E-01 |
| Normal-vs-Female |
1.231710E-02 |
| Male-vs-Female |
1.111180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.632970E-01 |
| Normal-vs-Age(41-60Yrs) |
2.961500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.258240E-01 |
| Normal-vs-Age(81-100Yrs) |
7.260000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.900600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.386400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.037400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.465200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.975030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.193400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.927520E-02 |
| Normal-vs-Grade 2 |
1.330370E-01 |
| Normal-vs-Grade 3 |
4.475000E-01 |
| Normal-vs-Grade 4 |
3.161900E-02 |
| Grade 1-vs-Grade 2 |
1.438570E-01 |
| Grade 1-vs-Grade 3 |
7.770200E-02 |
| Grade 1-vs-Grade 4 |
9.227200E-01 |
| Grade 2-vs-Grade 3 |
3.265000E-01 |
| Grade 2-vs-Grade 4 |
1.238430E-01 |
| Grade 3-vs-Grade 4 |
6.242000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.731820E-01 |
| Normal-vs-ccB subtype |
5.390100E-02 |
| ccA subtype-vs-ccB subtype |
3.566800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.670200E-02 |
| Normal-vs-N1 |
5.163900E-02 |
| N0-vs-N1 |
6.169900E-02 |
|
|
